Literature DB >> 17490406

Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.

Yue Zhang1, Qing Deng, Jaclyn A Porath, Carol L Williams, Kristin J Pederson-Gulrud, Joseph T Barbieri.   

Abstract

Pseudomonas aeruginosa ExoS (453 amino acids) is a bifunctional type III cytotoxin, comprising a Rho GTPase-activating protein domain (RhoGAP), and a 14-3-3 dependent ADP-ribosyltransferase domain. In addition, ExoS contains a membrane localization domain (termed MLD, residues 51-77) which localizes and traffics ExoS within intoxicated host cells. While membrane localization has been shown to be essential for ExoS to ADP-ribosylate Ras, the relationship between intracellular localization and expression of RhoGAP activity has not been addressed. In this study, loss of MLD function was observed to abolish expression of ExoS RhoGAP activity in HeLa cells. One mutation within the MLD (R56, R63, D70 mutated to N, RRD-->N) diminished plasma membrane localization and altered the cell rounding phenotype elicited by ExoS RhoGAP. In addition, cell rounding caused by ExoS-MLD(RRD-->N) was reversed by dominant active Rac1, but not dominant active Cdc42, indicating a switch in ExoS RhoGAP substrate specificity. Mutation of the C-terminal polybasic region abolished the ability of dominant active Rac1 to protect HeLa cells from expression of the RhoGAP activity of ExoS-MLD(RRD-->N). This study shows the importance of membrane localization in the targeting of Rho GTPases by ExoS RhoGAP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490406     DOI: 10.1111/j.1462-5822.2007.00949.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  9 in total

1.  Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins.

Authors:  Holly D Bullock; Suzanne Hower; Kenneth A Fields
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

2.  ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa.

Authors:  Michelle Cisz; Pei-Chung Lee; Arne Rietsch
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

3.  Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.

Authors:  Sheng Chen; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

4.  Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS.

Authors:  Victoria Hritonenko; David J Evans; Suzanne M J Fleiszig
Journal:  Microbes Infect       Date:  2012-08-30       Impact factor: 2.700

Review 5.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 6.  The type III secretion system of Pseudomonas aeruginosa: infection by injection.

Authors:  Alan R Hauser
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

7.  A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.

Authors:  Gregory H Tyson; Andrei S Halavaty; Hyunjin Kim; Brett Geissler; Mallory Agard; Karla J Satchell; Wonhwa Cho; Wayne F Anderson; Alan R Hauser
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.486

8.  Edwardsiella ictaluri T3SS Effector EseN Modulates Expression of Host Genes Involved in the Immune Response.

Authors:  Lidiya P Dubytska; Ranjan Koirala; Azhia Sanchez; Ronald Thune
Journal:  Microorganisms       Date:  2022-07-01

Review 9.  Bacterial toxin effector-membrane targeting: outside in, then back again.

Authors:  Brett Geissler
Journal:  Front Cell Infect Microbiol       Date:  2012-05-31       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.